Lanxess AG (LXS):企業の財務・戦略的SWOT分析

◆英語タイトル:Lanxess AG (LXS) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C0518
◆発行会社(調査会社):GlobalData
◆発行日:2018年7月
◆ページ数:55
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:化学
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Lanxess AG (LXS) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Lanxess AG (Lanxess) is a specialty chemical manufacturing company that manufactures and markets chemical intermediates, additives, specialty chemicals and plastics. It also supplies synthetic rubbers through a joint venture, ARLANXEO, with Saudi Aramco. Lanxess’ products find applications in agrochemicals, automotive, construction, pharmaceuticals, tire chemicals, electrical, electronics and medical equipment, leather processing and water treatment among others. Its major brands include Rhenogran, Aktiplast, Aflux, Mesamoll, Triacetin, Ultramoll, Bayferrox, Colortherm, Bayoxide, Velcorin, Virkon, Oxone, Durethan, Pocan, Tepex, Lewabrane, Adiprene, Vibrathane, Vibracure, Ultralast, Witcobond, Trixene, Isofoam and Lewatit. The company has operations in the Americas, Asia-Pacific and Europe. Lanxess is headquartered in Cologne, Germany.

Lanxess AG Key Recent Developments

Jul 23,2018: Lanxess names new UK boss
Jun 28,2018: LANXESS signs marketing and distribution cooperation agreement with filtration membranes and system manufacturer Polymem
Jun 11,2018: LANXESS Price Adjustment For PA 6 6 Compounds
Jun 11,2018: LANXESS Price Adjustment For PA 6 6 Compounds
May 30,2018: Lanxess: New Low Monomer Urethane Prepolymers For Adhesives And Sealants

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Section 1 – About the Company 6
Lanxess AG – Key Facts 6
Lanxess AG – Key Employees 7
Lanxess AG – Key Employee Biographies 8
Lanxess AG – Major Products and Services 9
Lanxess AG – History 12
Lanxess AG – Company Statement 16
Lanxess AG – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Joint Venture 19
Section 2 – Company Analysis 20
Company Overview 20
Lanxess AG – Business Description 21
Business Segment: Advanced Intermediates 21
Overview 21
Performance 21
Business Segment: ARLANXEO 21
Overview 21
Performance 22
Business Segment: Engineering Materials 22
Overview 22
Performance 22
Business Segment: Performance Chemicals 22
Overview 22
Performance 23
Business Segment: Specialty Additives 23
Overview 23
Performance 23
Geographical Segment: Asia-Pacific 24
Performance 24
Geographical Segment: EMEA (excluding Germany) 24
Performance 24
Geographical Segment: Germany 24
Performance 24
Geographical Segment: Latin America 24
Performance 24
Geographical Segment: North America 24
Performance 24
R&D Overview 24
Lanxess AG – Corporate Strategy 25
Lanxess AG – SWOT Analysis 26
SWOT Analysis – Overview 26
Lanxess AG – Strengths 26
Lanxess AG – Weaknesses 27
Lanxess AG – Opportunities 28
Lanxess AG – Threats 29
Lanxess AG – Key Competitors 30
Section 3 – Company Financial Ratios 31
Financial Ratios – Capital Market Ratios 31
Financial Ratios – Annual Ratios 32
Performance Chart 35
Financial Performance 35
Financial Ratios – Interim Ratios 36
Financial Ratios – Ratio Charts 37
Section 4 – Company’s, Lifesciences Financial Deals and Alliances 38
Lanxess AG, Petrochemicals, Deals By Year, 2012 to YTD 2018 38
Lanxess AG, Petrochemicals, Deals By Type, 2012 to YTD 2018 39
Lanxess AG, Recent Deals Summary 40
Section 5 – Company’s Recent Developments 41
Jun 28, 2018: LANXESS signs marketing and distribution cooperation agreement with filtration membranes and system manufacturer Polymem 41
Jun 11, 2018: LANXESS Price Adjustment For PA 6 6 Compounds 42
Jun 11, 2018: LANXESS Price Adjustment For PA 6 6 Compounds 43
May 30, 2018: Lanxess: New Low Monomer Urethane Prepolymers For Adhesives And Sealants 44
May 30, 2018: Lanxess: New Low Monomer Urethane Prepolymers For Adhesives And Sealants 45
May 15, 2018: LANXESS: Matthias L. Wolfgruber Voted In As New Chairman Of Supervisory Board 46
May 15, 2018: LANXESS: Matthias L. Wolfgruber Voted In As New Chairman Of Supervisory Board 47
May 03, 2018: LANXESS Renews Contract With CEO Matthias Zachert Ahead Of Time 48
Apr 03, 2018: Lanxess: Design Water Treatment Systems In Even More User-Friendly Process 49
Mar 19, 2018: Lanxess: Managing Heat Properly 50
Section 6 – Appendix 51
Methodology 51
Ratio Definitions 51
About GlobalData 55
Contact Us 55
Disclaimer 55

List of Tables
Lanxess AG, Key Facts 6
Lanxess AG, Key Employees 7
Lanxess AG, Key Employee Biographies 8
Lanxess AG, Major Products and Services 9
Lanxess AG, History 12
Lanxess AG, Subsidiaries 17
Lanxess AG, Joint Venture 19
Lanxess AG, Key Competitors 30
Lanxess AG, Ratios based on current share price 31
Lanxess AG, Annual Ratios 32
Lanxess AG, Annual Ratios (Cont...1) 33
Lanxess AG, Annual Ratios (Cont...2) 34
Lanxess AG, Interim Ratios 36
Lanxess AG, Petrochemicals, Deals By Year, 2012 to YTD 2018 38
Lanxess AG, Petrochemicals, Deals By Type, 2012 to YTD 2018 39
Lanxess AG, Recent Deals Summary 40
Currency Codes 51
Capital Market Ratios 51
Equity Ratios 52
Profitability Ratios 52
Cost Ratios 53
Liquidity Ratios 53
Leverage Ratios 54
Efficiency Ratios 54

List of Figures
Lanxess AG, Performance Chart (2013 - 2017) 35
Lanxess AG, Ratio Charts 37
Lanxess AG, Petrochemicals, Deals By Year, 2012 to YTD 2018 38
Lanxess AG, Petrochemicals, Deals by Type, 2012 to YTD 2018 39

★海外企業調査レポート[Lanxess AG (LXS):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Sompo Japan Nipponkoa Holdings, Inc.:企業の戦略・SWOT・財務情報
    Sompo Japan Nipponkoa Holdings, Inc. - Strategy, SWOT and Corporate Finance Report Summary Sompo Japan Nipponkoa Holdings, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Memry Corp:企業の戦略的SWOT分析
    Memry Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • Lennar Corp:企業の戦略・SWOT・財務情報
    Lennar Corp - Strategy, SWOT and Corporate Finance Report Summary Lennar Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Janssen Diagnostics LLC-医療機器分野:企業M&A・提携分析
    Summary Janssen Diagnostics LLC (Janssen), formerly Veridex, LLC, a subsidiary of Johnson & Johnson is a medical device company that develops and markets diagnostics products and solutions for the healthcare markets. The company’s products include circulating tumor cell kit, CTC control kit, CellSav …
  • Raisio plc:企業の戦略・SWOT・財務情報
    Raisio plc - Strategy, SWOT and Corporate Finance Report Summary Raisio plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Wells Fargo Clearing Services LLC:企業の戦略・SWOT・財務分析
    Wells Fargo Clearing Services LLC - Strategy, SWOT and Corporate Finance Report Summary Wells Fargo Clearing Services LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Air China Limited:企業のM&A・事業提携・投資動向
    Air China Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Air China Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), div …
  • Blue Cross and Blue Shield of Florida Inc:企業の戦略的SWOT分析
    Blue Cross and Blue Shield of Florida Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and …
  • APL Co Pte Ltd:企業の戦略的SWOT分析
    APL Co Pte Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Ferro Corp (FOE):企業の財務・戦略的SWOT分析
    Ferro Corp (FOE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • East African Breweries Ltd:企業の戦略・SWOT・財務分析
    East African Breweries Ltd - Strategy, SWOT and Corporate Finance Report Summary East African Breweries Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • SS&C Technologies Holdings Inc.:企業のM&A・事業提携・投資動向
    SS&C Technologies Holdings Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's SS&C Technologies Holdings Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers …
  • Dova Pharmaceuticals Inc (DOVA)-製薬・医療分野:企業M&A・提携分析
    Summary Dova Pharmaceuticals Inc (Dova) is a clinical-stage pharmaceutical company that develops therapies for the treatment of orphan diseases. The company’s lead candidate, Avatrombopag (AVA), a novel, oral thrombopoietin receptor agonist, is under development for the treatment of thrombocytopenia …
  • Cboe Global Markets, Inc (CBOE):企業の財務・戦略的SWOT分析
    Cboe Global Markets, Inc (CBOE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • MorphoSys AG (MOR)-製薬・医療分野:企業M&A・提携分析
    Summary MorphoSys AG (Morphosys) is a developer of monoclonal antibodies for therapeutic, diagnostic and research applications. The company’s pipeline product include MOR208, MOR202, MOR103, MOR209/ES414, MOR106, and MOR107, among others. It drugs are used in the treatment of different types of canc …
  • Close Brothers Asset Management:企業の戦略・SWOT・財務情報
    Close Brothers Asset Management - Strategy, SWOT and Corporate Finance Report Summary Close Brothers Asset Management - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Neusoft Corporation (600718):企業の財務・戦略的SWOT分析
    Neusoft Corporation (600718) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • 3D Oil Ltd Oil & Gas Exploration and Production Operations and Cost Analysis – 2017
    3D Oil Ltd Oil & Gas Exploration and Production Operations and Cost Analysis - 2017 Summary 3D Oil Ltd Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational a …
  • PSR Group BV-製薬・医療分野:企業M&A・提携分析
    Summary PSR Group BV (PSR) is a contract research organization and staffing consultancy that operates through two divisions, namely, PSR Orphan Experts and PSR Pharma Resource. The company’s PSR Orphan Experts is a contract research organization that concentrates on orphan drug development. It provi …
  • Protagen Protein Services GmbH-製薬・医療分野:企業M&A・提携分析
    Summary Protagen Protein Services GmbH (PPS), a subsidiary of Zukunftsfonds Heilbronn GmbH & Co KG is a contract research organization that concentrates on protein analytics. The organization offers services including protein characterization, services for biopharmaceuticals, biosimilars services an …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆